Evaluation of the digital diabetes prevention programme pilot: uncontrolled mixed-methods study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 05 2019
Historique:
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 3 6 2020
Statut: epublish

Résumé

The prevalence of type 2 diabetes is rising steeply. National Health Service England (NHSE) is exploring the potential of a digital diabetes prevention programme (DDPP) and has commissioned a pilot with embedded evaluation. This study aims to determine whether, and if so, how, should NHSE implement a national DDPP, using a mixed-methods pretest and post-test design, underpinned by two theoretical frameworks: the Coventry, Aberdeen and London - Refined (CALO-RE) taxonomy of behavioural change techniques for the digital interventions and the Consolidated Framework for Implementation Research (CFIR) for implementation processes. In eight pilot areas across England, adults with non-diabetic hyperglycaemia (NDH) (glycated haemoglobin (HbA1c) 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) and adults without NDH who are overweight (body mass index (BMI) >25 kg/m The study has received ethical approval from the Public Health England Ethics and Research Governance Group (reference R&D 324). Dissemination will include a report to NHSE to inform future policy and publication in peer-reviewed journals.

Identifiants

pubmed: 31122973
pii: bmjopen-2018-025903
doi: 10.1136/bmjopen-2018-025903
pmc: PMC6538049
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e025903

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JI is a partner and KD a management consultant at RSM. RSM hold the contract from NHSE to implement and evaluate the Digital Diabetes Prevention Programme. EM and WH receive consultancy fees for their work on the evaluation. EM is managing director of a not-for-profit Community Interest Company, HeLP-Digital, which exists to disseminate a digital diabetes self-management programme, HeLP-Diabetes, across the NHS. JV is the National Clinical Director for Diabetes and Obesity at NHS England.

Références

Diabet Med. 2018 Apr;35(4):513-518
pubmed: 29266374
J Med Internet Res. 2015 Jul 21;17(7):e181
pubmed: 26199208
Prev Med. 2017 Jul;100:194-207
pubmed: 28456513
Implement Sci. 2016 Oct 26;11(1):146
pubmed: 27782832
Diabet Med. 2012 Jul;29(7):855-62
pubmed: 22537247
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Ann Behav Med. 2017 Apr;51(2):226-239
pubmed: 27757789
BMC Med Res Methodol. 2006 May 03;6:20
pubmed: 16672056
Diabetes Res Clin Pract. 2011 Jan;91(1):1-12
pubmed: 20655610
Diabet Med. 2015 Apr;32(4):459-66
pubmed: 25439048
Ann Intern Med. 2015 Sep 15;163(6):465-8
pubmed: 26168073
BMC Health Serv Res. 2018 Mar 27;18(1):220
pubmed: 29587721
Psychol Health. 2011 Nov;26(11):1479-98
pubmed: 21678185
Am J Public Health. 2010 Nov;100(11):2193-8
pubmed: 20167901
Prev Med. 2018 Mar;108:93-110
pubmed: 29289643
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Health Psychol. 2019 Oct;24(12):1668-1675
pubmed: 28810415
Am J Prev Med. 2007 Oct;33(4):336-345
pubmed: 17888860
Health Technol Assess. 2011 Oct;15(37):1-160
pubmed: 22030014
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Curr Obes Rep. 2015 Dec;4(4):510-9
pubmed: 26364308
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Acad Nutr Diet. 2017 Mar;117(3):404-421.e36
pubmed: 28236962
Health Aff (Millwood). 2012 Jan;31(1):67-75
pubmed: 22232096
J Gen Intern Med. 2015 Mar;30(3):284-9
pubmed: 25387437
Obes Rev. 2016 Jun;17(6):541-51
pubmed: 26948257
Eur J Public Health. 2016 Aug;26(4):602-10
pubmed: 27335330
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Am J Prev Med. 2016 Nov;51(5):833-842
pubmed: 27745683
Diabetes Care. 2014 Apr;37(4):922-33
pubmed: 24652723
BMC Med Inform Decis Mak. 2016 Sep 15;16(1):120
pubmed: 27630020
J Med Internet Res. 2018 Mar 22;20(3):e106
pubmed: 29567638
J Diabetes Res. 2017;2017:2615681
pubmed: 28890899
J Med Internet Res. 2017 Apr 27;19(4):e136
pubmed: 28450271
Am J Prev Med. 2017 Oct;53(4):519-532
pubmed: 28688727
Diabetes Educ. 2016 Apr;42(2):153-65
pubmed: 26879459
Am J Prev Med. 2016 Nov;51(5):852-860
pubmed: 27745685
Int J Behav Nutr Phys Act. 2014 Jan 15;11:2
pubmed: 24423095
J Am Heart Assoc. 2016 Aug 31;5(9):
pubmed: 27581172
J Med Internet Res. 2013 Aug 30;15(8):e162
pubmed: 23996958

Auteurs

Elizabeth Murray (E)

Research Department of Primary Care and Population Health, University College London, London, UK.

Kerry Daff (K)

RSM UK Consulting LLP, Belfast, UK.

Anthi Lavida (A)

Primary Care and Population Health, University College London, London, UK.

William Henley (W)

Institute of Health Research, University of Exeter Medical School, Exeter, UK.

Jenny Irwin (J)

RSM UK Consulting LLP, Belfast, UK.

Jonathan Valabhji (J)

Medical Directorate, NHS England, London, UK.
Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH